Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Axcelis Technologies Q1 2026 Earnings Call - Memory Momentum Offsets Mature Node Digestion
Axcelis reported Q1 2026 revenue of $199 million and EPS of $0.72, slightly beating expectations despite a $5 million one-time customer settlement headwind. The company’s CS&I business delivered stron...
- Q1 2026 revenue came in at $199 million, with EPS of $0.72, slightly above guidance after accounting for a $5 million one-time customer settlement headwind.
- CS&I revenue grew over 30% year-over-year, exceeding management expectations and reflecting stronger service, consumables, and system upgrade demand.
- Memory market system shipments reached their highest level since Q4 2023, with meaningful sequential increases in both revenue and bookings driven by AI-related DRAM capacity investments.
- +7 more takeaways
"Absci" Q1 2026 Earnings Call - Prolactin Pipeline Expansion and Oncology Pivot
Absci's Q1 2026 update centers on a strategic pivot away from oncology toward a concentrated focus on its prolactin receptor pipeline, led by the lead asset ABS-201 for androgenetic alopecia (AGA) and...
- Absci is pivoting its strategic focus away from oncology, halting internal development of assets ABS-301 and ABS-501 to concentrate capital and resources on its prolactin receptor pipeline.
- The company announced a new anti-prolactin receptor antibody, ABS-202, for an undisclosed immune-inflammatory (I&I) indication, expanding its early-stage pipeline beyond AGA and endometriosis.
- ABS-201 for androgenetic alopecia (AGA) remains the lead asset, with the Phase I/IIa headline trial on track and all four single ascending dose cohorts fully dosed.
- +7 more takeaways
ZipRecruiter Q1 2026 Earnings Call - AI-Driven Engagement Surges Amid Muted Hiring Cycle
ZipRecruiter delivered a resilient Q1 2026, posting $107.5 million in revenue and beating guidance on both the top and bottom lines. The company is leveraging its next-generation AI matching engine an...
- Revenue of $107.5 million beat the midpoint of guidance, representing a 2% year-over-year decline and a 4% sequential decline driven by post-holiday seasonality and a soft macro backdrop.
- Adjusted EBITDA came in at $9.7 million, a 9% margin that significantly exceeded the high end of the guidance range, up from 5% in Q1 2025.
- ZipRecruiter launched its next-generation AI search and matching engine, resulting in a 37% increase in application volume for job seekers exposed to the new algorithm.
- +7 more takeaways
BridgeBio Pharma Q1 2026 Earnings Call - ATTRUBY Surges 392% as BridgeBio Launches $500M Buyback Amid Pipeline Readiness
BridgeBio Pharma delivered a blockbuster Q1 2026, with ATTRUBY net revenue skyrocketing 392% year-over-year to $180.6 million. The drug is on track to become a $4 billion franchise, buoyed by accelera...
- ATTRUBY Q1 2026 net revenue surged 392% YoY to $180.6 million, driven by accelerating first-line market share gains and new patient starts exceeding 6,100 per quarter.
- Real-world evidence is mounting: a Nevada system study showed statistically significant outcome improvements for acoramidis versus tafamidis, and a medRxiv paper indicates a 43% reduction in diuretic intensification.
- Management now forecasts ATTRUBY to be a $4 billion drug, with confidence that growth will extend well past the 2031/2032 patent cliff due to Part D’s continuous plan structure and clinical differentiation.
- +7 more takeaways
VTEX Q1 2026 Earnings Call - AI-Native Commerce Suite Drives Margin Expansion Amid Brazil Headwinds
VTEX reported mixed results for Q1 2026, with top-line growth moderating due to persistent macro headwinds in Brazil, but profitability and cash generation surged. GMV reached $5.1 billion, up 17% yea...
- GMV reached $5.1 billion in Q1 2026, representing 17% year-over-year growth in USD, though FX-neutral growth moderated to 7% due to persistent macro headwinds in Brazil.
- Non-GAAP operating income doubled to $10.6 million, reflecting a 17.4% operating margin and demonstrating significant operational leverage despite slower top-line growth.
- Free cash flow surged to $13.3 million, doubling year-over-year and achieving a robust 21.9% free cash flow margin, underscoring the company's disciplined capital allocation.
- +7 more takeaways
Expedia Group Q1 2026 Earnings Call - Margin Expansion and AI Strategy Drive Strong Performance
Expedia Group delivered a robust Q1 2026, exceeding expectations with 13% gross bookings growth, 15% revenue growth, and a near 6-point expansion in EBITDA margins to 15.8%. The quarter was marked by ...
- Gross bookings grew 13% to $35.5 billion, with revenue up 15% to $3.4 billion, beating the high end of guidance.
- Adjusted EBITDA margin expanded nearly 6 points year-over-year to 15.8%, marking the highest Q1 margin in 15 years.
- Consumer bookings grew 10%, the fastest pace in 12 quarters, driven by strong performance across Expedia, Vrbo, and Hotels.com.
- +7 more takeaways
IRSA Q3 2026 Earnings Call - Record Dollar EBITDA Amidst Tenant Sales Pressure and Major Development Push
IRSA delivered a robust nine-month fiscal 2026 performance, posting a net gain of ARS 239.7 billion and driving rental adjusted EBITDA to a record $151 million in dollar terms. The company’s diversifi...
- IRSA posted a nine-month fiscal 2026 net gain of ARS 239.7 billion, a substantial increase from ARS 46.5 billion in the prior year period.
- Rental adjusted EBITDA reached a record $151 million in dollar terms, driven by real-dollar growth across all three core segments.
- Shopping mall occupancy remained near 98%, with fixed revenue components now accounting for approximately 87% of total mall revenues.
- +7 more takeaways
Cerence (CRNC) Q2 2026 Earnings Call - xUI Production Ramp and Raised Full-Year Guidance
Cerence delivered a strong Q2 2026 quarter, with revenue of $64.2 million and adjusted EBITDA of $7.2 million, both exceeding the high end of guidance. The company is successfully transitioning its co...
- Revenue of $64.2 million and adjusted EBITDA of $7.2 million beat the high end of guidance, while free cash flow came in at $13.6 million.
- Cerence raised full-year 2026 revenue guidance to $305-320 million and adjusted EBITDA to $60-70 million, with free cash flow guidance increasing by $10 million.
- BYD has become the first OEM to ship vehicles with Cerence’s xUI platform, with additional programs from JLR, VW Group, Geely, and a major Japanese automaker expected to ramp through 2026.
- +7 more takeaways
Atlanticus Holdings Q1 2026 Earnings Call - Mercury Integration Accelerates as Legacy Portfolios Surge 35%
Atlanticus Holdings delivered a standout first quarter of 2026, driven by a powerful combination of legacy portfolio expansion and the rapid integration of the Mercury Financial acquisition. Earnings ...
- Earnings per share surged 50% year-over-year to $2.23, with net income reaching $41.9 million, reflecting strong execution and acquisition synergy realization.
- Total operating revenue jumped 97% year-over-year to $680 million, with Mercury contributing $224 million and legacy portfolios showing robust organic growth.
- Managed receivables excluding Mercury grew 35% year-over-year, driven by share gains in private label and general purpose product lines, indicating aggressive market expansion.
- +7 more takeaways
Grove Collaborative Holdings Inc Q1 2026 Earnings Call - Revenue Trough Expected with Profitability Milestone
Grove Collaborative Holdings reported a first quarter that defied the lingering drag of its 2025 platform migration, delivering net revenue of $36.2 million and marking its second consecutive quarter ...
- Grove reported Q1 2026 net revenue of $36.2 million, down 16.8% year-over-year, but management explicitly identifies this period as the revenue trough for the full year.
- The company achieved positive adjusted EBITDA of $0.3 million, marking its second consecutive quarter of profitability and reflecting aggressive cost discipline.
- Full-year 2026 revenue guidance was raised to $142.5 million–$152.5 million, up from the previous range of $140 million–$150 million.
- +7 more takeaways